Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-23-003521)

Filing Details

Accession Number:: 0001562180-23-003521
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-04-12 16:03:51
Reporting Period:: 2023-04-10

Accepted Time:: 2023-04-12 16:03:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1395937	Syndax Pharmaceuticals Inc	SNDX	Pharmaceutical Preparations (2834)	320162505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1654430	Briggs Morrison	C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-10	52,855	$6.38	70,691	No	4	M	Direct
Common Stock	Disposition	2023-04-10	52,855	$19.53	17,836	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to buy)	Disposition	2023-04-10	52,855	$0.00	52,855	$6.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2029-02-06	No	4	M	Direct

Footnotes

Following the sales reported in this Form 4, the Reporting Person has a total of 727,145 options to purchase shares of common stock that are vested and immediately exercisable and a total of 291,292 options to purchase shares of common stock that have not yet vested.
The sale prices ranged from $19.28 to $20.11.
This option is fully vested.